Clinical information
| Patient ID . | Sex/age, y . | Source . | Percentage of blasts . | Stage . | Immunophenotype . | Cytogenetics . |
|---|---|---|---|---|---|---|
| 1345 | F/5 | BM | 95 | D | CD10+ | 45 XX dup(1)(q42 q25), del(3)(q21), −9, del(9)(p22), t(18;20)(q21q13.1) |
| 1999 | F/14 | BM | 94 | D | CD10+CD34− | 46 XX |
| 0398 | M/15 | BM | 96 | R | CD10−CD34+ | 46 XY add(3)(q29) t(14:19)(q32p13) |
| 1196 | F/8 | BM | NA | D | CD10+CD34− | 46 XX −19,del(19), t(1;19)(q23p13) |
| 2032 | M/12 | BM | NA | D | CD10+CD34− | 46 XY add (9)(p24), del(9)(p21), del(13)(q11q21), der(19) t(1;19)(q23;p13) |
| Patient ID . | Sex/age, y . | Source . | Percentage of blasts . | Stage . | Immunophenotype . | Cytogenetics . |
|---|---|---|---|---|---|---|
| 1345 | F/5 | BM | 95 | D | CD10+ | 45 XX dup(1)(q42 q25), del(3)(q21), −9, del(9)(p22), t(18;20)(q21q13.1) |
| 1999 | F/14 | BM | 94 | D | CD10+CD34− | 46 XX |
| 0398 | M/15 | BM | 96 | R | CD10−CD34+ | 46 XY add(3)(q29) t(14:19)(q32p13) |
| 1196 | F/8 | BM | NA | D | CD10+CD34− | 46 XX −19,del(19), t(1;19)(q23p13) |
| 2032 | M/12 | BM | NA | D | CD10+CD34− | 46 XY add (9)(p24), del(9)(p21), del(13)(q11q21), der(19) t(1;19)(q23;p13) |
D indicates diagnosis; NA, not available; and R, relapse.